Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940 SHE) stock market data APIs
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Financial Data Overview
Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, antihypertensive, digestive system, central nervous diseases, and respiratory preparations. The company was founded in 2001 and is based in Shengzhou, China.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Zhejiang Anglikang Pharmaceutical Co Ltd Class A data using free add-ons & libraries
Get Zhejiang Anglikang Pharmaceutical Co Ltd Class A Fundamental Data
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Fundamental data includes:
- Net Revenue: 1 451 M
- EBITDA: 184 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get Zhejiang Anglikang Pharmaceutical Co Ltd Class A Earnings data
What’s included:
- Latest Release: 2025-04-25
- EPS/Forecast: NaN
Get Zhejiang Anglikang Pharmaceutical Co Ltd Class A End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
